Cathay Pacific has become a full member of Pharma.Aero, a cross-industry collaboration for pharma shippers, CEIV-certified cargo communities, airport operators and other air cargo industry stakeholders. Cathay Pacific has been CEIV Pharma certified since October 2017.
Pharma.Aero, whose aim is to achieve excellence in the reliable, end-to-end air transportation and handling of high-value, time-sensitive pharmaceutical products, announced Cathay Pacific’s membership today at the IATA World Cargo Symposium in Singapore.
Cathay Pacific General Manager Cargo Commercial Nelson Chin said: “This collaborative approach with the pharmaceutical industry undoubtedly boosts Hong Kong’s reputation as a world-class hub for the handling of these high-value and time-sensitive products.
“As Hong Kong’s home airline, Cathay Pacific is working closely with Airport Authority Hong Kong to develop a pharma ‘corridor’ to connect airport members of Phama.Aero and provide customers with a superior service.”
Pharmaceutical shipments travelling the corridor will be handled in strict compliance with the IATA’s CEIV Pharma standard. Shippers will be assured of seamless airport-to-airport (A2A) temperature-controlled handling, assuring the integrity of the shipments.
Nathan De Valck, Chairman of Pharma.Aero added: “We are excited about Cathay Pacific joining our collaboration group as a full member. Their active involvement in the pilot of the pharma corridor project is a clear added value. In collaboration with Pharma.Aero and our pharma shipper members, key performance indicators of the pharma corridor will be clearly defined, targeting to set A2A pharma handling standards.”